Has Marcus Dilallo, MD received payments from drug or device companies?

Yes. Drug and device makers reported $26,080 in general payments to Marcus Dilallo, MD across 77 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Marcus Dilallo, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Marcus Dilallo, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Marcus Dilallo, MD

Orthopaedic Surgery · Raleigh, NCNPI 1033614946

Payments from drug & device makers

$26,080in general payments, 2019–2025

Across 77 payments — averaging $338.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$18K
Zimmer Biomet$5K
Stryker$2K
Pacira Pharmaceuticals Incorporated$671
Johnson & Johnson$625
Medical Device Business Services, Inc.$183
plus $172 from 1 others

What the payments were for

Grants$8,75034%
Travel & lodging$4,93119%
Food & beverage$3,40413%
Education$8,99634%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	11	$18,073
Zimmer Biomet	25	$4,617
Stryker	28	$1,739
Pacira Pharmaceuticals Incorporated	6	$671
Johnson & Johnson	2	$625
Medical Device Business Services, Inc.	4	$183
Medtronic	1	$172

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,080 in reported general payments places this provider in the 75th percentile of 845 orthopaedic surgery providers in North Carolina.

See all orthopaedic surgery providers in North Carolina →

Medicare billing

Part B allowed, 2024

$23,654

Medicare patients

Services billed

315

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Omeprazole	15	$101
Oxycodone Hcl	15	$100
Meloxicam	30	$81
Cefadroxil	11	$67

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Raleigh

Gurvinder DeolRaleigh$2.8M
Rhett HallowsRaleigh$388K
John NelsonRaleigh$234K
Thomas FehringCharlotte$18.3M
Walter BeaverCharlotte$7.4M
Robert AndersonCharlotte$6.6M
William JiranekDurham$6.4M
John MasonCharlotte$6.2M
Thomas VailDurham$5.7M
William DavisCharlotte$5.2M

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →